Clearside Biomedical to Pursue Strategic Sale Through Voluntary Chapter 11 Process
Clearside Biomedical, a biopharmaceutical company, has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. As part of the case, Clearside also intends to file a motion...
Read moreDetails










